Editas Medicine
Price & Volume
Stats
See moreOpen | $2.53 |
Previous Close | $2.58 |
Day Range | $2.42-$2.53 |
52W Range | $1.66-$4.53 |
Market Cap | $396.2M |
Shares Short | 29M |
Financials
See moreRevenue (12 Mos) | $47M |
Revenue Growth (YoY) | 232.3% |
Gross Profit (12 Mos) | -$37.9M |
Diluted EPS | -$0.66 |
News
See moreYahoo Finance • 6 days ago
Microsoft upgraded, HubSpot initiated: Wall Street's top analyst calls
Yahoo Finance • last month
Biotech Breakout: What's in focus after Moderna's cancer win?
Yahoo Finance • last month
4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains
Yahoo Finance • 4 months ago
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
About
CEO | Dr. Gilmore O'Neill M.D. |
CFO | Ms. Amy Parison |
Address | 11 Hurley Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 87 |